Showing 441 - 460 results of 1,727 for search '"Fibrosis"', query time: 0.07s Refine Results
  1. 441
  2. 442

    TXNIP deficiency attenuates renal fibrosis by modulating mTORC1/TFEB-mediated autophagy in diabetic kidney disease by Yunxia Du, Ming Wu, Shan Song, Yawei Bian, Yonghong Shi

    Published 2024-12-01
    “…Taken together, these findings suggest that TXNIP deficiency ameliorates renal fibrosis by regulating mTORC1/TFEB-mediated autophagy in diabetic kidney diseases.…”
    Get full text
    Article
  3. 443

    Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats. by Cheng Li, Xulong Chen, Jingchun Yao, Weiwei Zha, Meiren Li, Jiangwen Shen, Hongli Jiang, PuXun Tian

    Published 2025-01-01
    “…This study aims to investigate the potential anti-renal fibrosis effects of CUR from the gut microbiota perspective. …”
    Get full text
    Article
  4. 444

    Combined Pulmonary Fibrosis and Emphysema Syndrome: A New Phenotype within the Spectrum of Smoking-Related Interstitial Lung Disease by Karina Portillo, Josep Morera

    Published 2012-01-01
    “…Combined pulmonary fibrosis and emphysema (CPFE) is a recently defined syndrome, in which centrilobular and/or paraseptal emphysemas in upper lung zones coexist with pulmonary fibrosis in lower lobes in individuals. …”
    Get full text
    Article
  5. 445
  6. 446
  7. 447
  8. 448

    Factores de riesgo para hepatocarcinoma en pacientes con fibrosis avanzada o cirrosis por virus C by Yusimik Roman Martinez, Rosmy Fabiola Aguilar Aguilar, Marlén Castellanos Fernández, Sila María González Suero, Rebeca Winograd Lay, Mirtha Infante Velázquez

    Published 2024-06-01
    “…Introducción: La eliminación del virus de la hepatitis C con el tratamiento antiviral no excluye el riesgo de carcinoma hepatocelular en pacientes con fibrosis avanzada/cirrosis. Objetivos: Describir la frecuencia de factores de riesgo en pacientes con fibrosis F3/F4 tratados con antivirales de acción directa que alcanzaron la respuesta viral virológica sostenida. …”
    Get full text
    Article
  9. 449

    Exploring Liraglutide’s mechanism in reducing renal fibrosis: the Fsp1-CoQ10-NAD(P)H pathway by Qi Chen, Ji-Xian Song, Zhi Zhang, Ji-Ren An, Yu-Jing Gou, Miao Tan, Yashuo Zhao

    Published 2025-01-01
    “…Abstract Studies have confirmed that elevated glucose levels could lead to renal fibrosis through the process of ferroptosis. Liraglutide, a human glucagon-like peptide-1 (GLP-1) analogue, is a potential treatment option for diabetes. …”
    Get full text
    Article
  10. 450
  11. 451
  12. 452
  13. 453

    The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B by Qingqing Zhang, Qidi Zhang, Binghang Li, Ying Qu, Zhenghong Li, Lungen Lu, Rongzhou Li, Xiaobo Cai

    Published 2021-01-01
    “…A logistic regression analysis was performed to assess factors associated with fibrosis progression. The receiver operating characteristic (ROC) curve and discriminant analyses validated the ability of these predicted variables to discriminate the nonsignificant liver fibrosis group from the significant liver fibrosis group. …”
    Get full text
    Article
  14. 454
  15. 455

    PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients by Ana Virseda-Berdices, Ana Virseda-Berdices, Óscar Brochado-Kith, Óscar Brochado-Kith, Juan Berenguer, Juan Berenguer, Juan Berenguer, Juan González-García, Juan González-García, Juan González-García, Leire Pérez-Latorre, Leire Pérez-Latorre, Leire Pérez-Latorre, Carmen Busca, Carmen Busca, Carmen Busca, Cristina Díez, Cristina Díez, Cristina Díez, Rafael Micán, Rafael Micán, Rafael Micán, Amanda Fernández-Rodríguez, Amanda Fernández-Rodríguez, María Ángeles Jiménez-Sousa, María Ángeles Jiménez-Sousa, Salvador Resino, Salvador Resino

    Published 2025-01-01
    “…Two SDE genes achieved excellent discrimination ability: NCAPG had an AUROC of 0.908, NHLRC1 of 0.879, and a logistic regression model with these two genes of 0.955.ConclusionA pre-treatment gene expression signature in PBMCs was associated with liver fibrosis regression (LSMred>50%) after achieving HCV clearing with HCV therapy in HIV/HCV-coinfected patients, where two SDE genes (NCAPG and NHLRC1) showed the greatest predictive capacity, which could be used as a noninvasive marker of liver fibrosis regression.…”
    Get full text
    Article
  16. 456
  17. 457

    Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats by Shuyu Ge, Zhenghong Guo, Ting Xiao, Pingping Sun, Bo Yang, Yin Ying

    Published 2024-01-01
    “…As an interstitial fibrosis disease characterized by diffuse alveolitis and structural alveolar disorders, idiopathic pulmonary fibrosis (IPF) has high lethality but lacks limited therapeutic drugs. …”
    Get full text
    Article
  18. 458

    Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients by Somaya Hashem, Gamal Esmat, Wafaa Elakel, Shahira Habashy, Safaa Abdel Raouf, Samar Darweesh, Mohamad Soliman, Mohamed Elhefnawi, Mohamed El-Adawy, Mahmoud ElHefnawi

    Published 2016-01-01
    “…Liver fibrosis was assessed via METAVIR score; patients were categorized as mild to moderate (F0–F2) or advanced (F3-F4) fibrosis stages. …”
    Get full text
    Article
  19. 459
  20. 460

    Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study by Shan Hong, Ziyu Liu, Ping Li, Jing Zhang, Hongshan Wei

    Published 2025-01-01
    “…A new algorithm based on GP73 was developed with a higher area under ROC (AUC) of 0.840 than that of Fibrosis index-4 (p< 0.001).ConclusionsSerum GP73 is an independent risk factor for significant liver fibrosis in MASLD, and the GFA (GP73-Fibroscan-Age) model has good diagnostic efficacy for significant liver fibrosis.…”
    Get full text
    Article